DERMATOLOŠKI IZAZOVI U PANDEMIJI KOVID-19: ZNAČAJ DERMOKOZMETIČKIH PREPARATA
Sažetak
Iako je KOVID-19 češće prisutan u blažoj formi, sistemski poremećaji uzrokovani virusom ogledaju se na gotovo svim organima. Dermatološke manifestacije su posledica same bolesti kao i preventivnih mera koje se preduzimaju u cilju sprečavanja infekcije. Uglavnom ne zahtevaju farmakoterapiju osim u težim slučajevima. U radu su istaknuti neželjeni događaju na koži u vezi sa svim aspektima KOVID-19 sa ciljem da se pruži sveobuhvatan pregled i osvetli uloga i značaj dermokozmetičkih preparata u njihovom tretmanu. U pripremi pregleda identifikovani su faktori koji utiču na kožu u pandemiji (zaštitne mere, sama bolest, post KOVID sindrom), uz selekciju i klasifikaciju kožnih simptoma koji se mogu tretirati dermokozmetičkim preparatima, i to prema relevantnim naučnim radovima i smernicama.
Dermatološki izazovi u pandemiji KOVID-19 mogu se podeliti u tri glavne kategorije: 1) kožne manifestacije u vezi sa samom infekcijom; 2) manifestacije kao rezultat nošenja zaštitne opreme i upotrebe sredstava za dezinfekciju i 3) kožne manifestacije post KOVID sindroma. Dermokozmetički preparati, jedinstvena kategorija kozmetičkih proizvoda sa terapeutskim efektima se preporučuju svuda osim kod teških dermatoloških poremećaja povezanih sa KOVID-19. Zauzimaju važno mesto u radu dermatologa, a pandemija KOVID-19 potvrđuje njihov značaj.
Reference
REFERENCES
1. Cao X. COVID-19: immunopathology and its implications for therapy. Nature reviews immunology. 2020 May;20(5):269-70.
2. Spick M, Longman K, Frampas C, Lewis H, Costa C, Walters DD, Stewart A, Wilde M, Greener D, Evetts G, Trivedi D, Barran P, Pitt A, Bailey M. Changes to the sebum lipidome upon COVID-19 infection observed via rapid sampling from the skin. EClinicalMedicine. 2021 Mar;33:100786.
3. Searle T, Ali FR, Al-Niaimi F. Identifying and addressing "Maskne" in clinical practice. Dermatol Ther. 2021 Jan;34(1):e14589.
4. Rundle CW, Presley CL, Militello M, Barber C, Powell DL, Jacob SE, Atwater AR, Watsky KL, Yu J, Dunnick CA. Hand hygiene during COVID-19: Recommendations from the American Contact Dermatitis Society. J Am Acad Dermatol. 2020 Dec;83(6):1730-1737.
5. Nabavi N. Long covid: how to define it and how to manage it. BMJ. 2020;370:m3489.
6. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
7. Drenovska K, Schmidt E, Vassileva S. Covid-19 pandemic and the skin. Int J Dermatol. 2020 Nov;59(11):1312-1319.
8. Genovese G, Moltrasio C, Berti E, Marzano AV. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology. 2021;237(1):1-12.
9. Tan SW, Tam YC, Oh CC. Skin manifestations of COVID-19: A worldwide review. JAAD International, 2021 (2): 119-133.
10. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213.
11. Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. 2020 Sep;183(3):431–42.
12. Galván Casas C, Català A, Carretero Hernández G, et al. Classifi cation of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183(1):71–77.
13. Krajewski PK, Maj J, Szepietowski JC. Cutaneous hyperaesthesia in SARS-CoV-2 infection: rare but not unique clinical manifestation. Acta Derm Venereol 2021; 101(1):adv00366.
14. Atzori L, Recalcati S, Ferreli C, Hoenig LJ, Rongioletti F. COVID-19–related skin manifestations: Update on therapy. Clinics in Dermatology 2021; 39 (5)2021: 920-926.
15. Moncrieff G, Van Onselen J, Young T (2015) The role of emollients in maintaining skin integrity. Wounds UK; 11 (1): 68-74.
16. Kim J, Yoo S, Kwon OS, Jeong ET, Lim JM, Park SG. Influence of quarantine mask use on skin characteristics: One of the changes in our life caused by the COVID‐19 pandemic. Skin Research and Technology. 2020 Dec 28.
17. Park SR, Han J, Yeon YM, Kang NY, Kim E. Effect of face mask on skin characteristics changes during the COVID‐19 pandemic. Skin Research and Technology. 2020 Nov 20.
18. Tasic-Kostov M, Martinović M, Ilic D, Cvetkovic M. Cotton versus medical face mask influence on skin characteristics during COVID-19 pandemic: A short-term study. Skin Res Technol. 2022 Jan;28(1):66-70.
19. Teo WL. Diagnostic and management considerations for “maskne” in the era of COVID-19. Journal of the American Academy of Dermatology. 2020 Oct 1.
20. Yan Y, Chen H, Chen L, et al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Dermatologic Therapy. 2020; e13310.
21. Teo WL. Diagnostic and management considerations for "maskne" in the era of COVID-19. J Am Acad Dermatol. 2021 Feb;84(2):520-521.
22. Dréno B, Dagnelie MA, Khammari A, Corvec S. The Skin Microbiome: A New Actor in Inflammatory Acne. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):18-24. doi: 10.1007/s40257-020-00531-1.
24. Wollina U. Challenges of COVID-19 pandemic for dermatology. Dermatol Ther. 2020;33(5):e13430
25. Akl J, El- Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol. 2021;20:3105–3115.
26. Stettler, H.; de Salvo, R.; Brandt, M.; Effertz, A.-K.; Laing, S.; Trapp, S. Performance and Acceptability of a New Dexpanthenol-Containing Hand Cream in Subjects with Sensitive and Very Dry Skin: A Randomized Controlled Study. Cosmetics 2022, 9, 44.
27. https://www.aad.org/public/everyday-care/skin-care-basics/dry/coronavirus-handwashing
28. Diotallevi, F., Mazzanti, S., Properzi, P., Olivieri, S., Giacometti, A. and Offidani, A. (2022), Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single centre. J Eur Acad Dermatol Venereol, 36: e166-e169.
29. Müller-Ramos, P., Ianhez, M., Silva de Castro, C.C., Talhari, C., Criado, P.R. and Amante Miot, H. (2022), Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients. Int J Dermatol, 61: e162-e164
30. McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, French LE, Lim H, Cyster JG, Fox LP, Fassett MS, Freeman EE. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021 Mar;21(3):313-314.
31. Rogers, N.E. (2013). Cosmeceuticals for Hair Loss and Hair Care. In Cosmeceuticals and Cosmetic Practice, P.K. Farris (Ed.).